Press release
Pharmacogenomics Market: Business Outlook and Growth Forecast by 2031 | Abbott Laboratories, Agilent Technologies Inc
Pharmacogenomics Market
Pharmacogenomics Market analysis, according to DataM Intelligence, offers more than just an overview, it investigates the underlying aspects of the sector. The study provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Get a Free Sample PDF copy of the report - https://datamintelligence.com/download-sample/pharmacogenomics-market
The Pharmacogenomics market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.
Pharmacogenomics is the branch of science that studies how an individual's genetic makeup influences their response to medications. It integrates pharmacology (the science of drugs) with genomics (the study of genes and their functions) to understand how genetic variations affect drug metabolism, efficacy, and safety.
The goal of pharmacogenomics is to develop personalized medicine, where treatments and drug dosages are tailored to a patient's genetic profile, reducing adverse effects and improving therapeutic outcomes. This approach is particularly valuable in areas like oncology, cardiology, and psychiatry.
Forecast Growth Projected:
The Global Pharmacogenomics Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Pharmacogenomics Market:
Abbott Laboratories, Agilent Technologies Inc, Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories Inc, Illumine, Eurofins Scientific, Pacific Biosciences of California Inc, Qiagen and Thermo Fisher Scientific Inc
Transform Your Strategy with Expert Market Analysis: https://www.datamintelligence.com/competitive-intelligence
Segment Covered in the Pharmacogenomics Market:
By Type: Genotyping Kits, Sequencing Instruments, PCR Reagents and Consumables, Sample Preparation Kits, Others, ServicesGenetic Testing Services, Pharmacogenomic Consulting, Others, SoftwareBioinformatics Software, Clinical Decision Support System, Laboratory Information Management System, EHR Integration Software, Others
By Technology: DNA Sequencing , Microarray, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Other Technologies
By Application: Drug Discovery, Neurology, Oncology, Pain Management, Other Applications
By End User: Hospital , Specialty Clinics, Academic and Research Institutes, Pharmaceuticals
Industry Development:
On July 25, 2023, Illumina Inc. announced a collaboration with Pillar Biosciences Inc. to integrate Pillar's oncology assays into Illumina's portfolio. This partnership aims to expand the range of sequencing options, offering more efficient, accurate, and cost-effective cancer testing solutions. The collaboration is expected to improve access to personalized cancer treatments.
On May 9, 2023, Pfizer and Thermo Fisher Scientific entered into a partnership to enhance personalized next-generation sequencing-based testing for cancer patients in international markets. The agreement focuses on improving access to advanced genetic testing for breast and lung cancer in over 30 countries where such testing is currently limited or unavailable, enabling localized and affordable solutions for patients.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=pharmacogenomics-market
Regional Break out:
The global Pharmacogenomics Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Pharmacogenomics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Pharmacogenomics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/pharmacogenomics-market
Frequently asked questions:
➠ What is the global sales value, production value, consumption value, import and export of Pharmacogenomics market?
➠ Who are the global key manufacturers of the Pharmacogenomics Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?
➠ What are the Pharmacogenomics market opportunities and threats faced by the vendors in the global Pharmacogenomics Industry?
➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➠ What focused approach and constraints are holding the Pharmacogenomics market?
➠ What are the different sales, marketing, and distribution channels in the global industry?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Market: Business Outlook and Growth Forecast by 2031 | Abbott Laboratories, Agilent Technologies Inc here
News-ID: 3825490 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Japan Single-Use Bioprocessing Products Market: Thermo Fisher, Sartorius & Cytiv …
Market Size and Forecast:
Japan Single-Use Bioprocessing Products Market is expected to reach growth at a Significant CAGR during the forecast period 2024-2031
The Japan Single-Use Bioprocessing Products Market Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of…
United States Pharmaceutical Packaging Market to Grow at 9.5% CAGR, Driven by Re …
The global Pharmaceutical Packaging Market is growing at a CAGR of 9.5% during the forecast period 2024-2031, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Amcor PLC launched a new series of recyclable cold-chain packaging solutions for biologic drugs, enhancing sustainability in temperature-sensitive shipments.
✅ In October 2025, West Pharmaceutical Services introduced a novel smart vial system with integrated sensors for real-time temperature and tamper monitoring.
✅…
United States Optical Imaging Market to Grow at 12.4% CAGR, Reaching USD 4.0 bil …
The global Optical Imaging Market reached USD 1.6 billion in 2022 and is projected to reach USD 4.0 billion by 2031, growing at a CAGR of 12.4% during the forecast period 2024-2031, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Canon U.S.A. received FDA clearance for its next-generation optical coherence tomography (OCT) system with AI-enhanced diagnostic capabilities for ophthalmology.
✅ In October 2025, Abbott Laboratories…
United States Precious Metal Market to Grow at 5.2% CAGR, Led by Newmont Corpora …
The global Precious Metal Market reached USD 209.4 billion in 2023 and is projected to reach USD 300.3 million by 2031, growing at a CAGR of 5.2% during the forecast period 2024-2031, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Newmont Corporation announced the expansion of its Nevada Gold Mines complex, increasing gold production capacity by 15% through advanced extraction technologies.
✅ In October 2025, The…
More Releases for Pharmacogenomic
Molecular Diagnostics in Pharmacogenomics Market to Reach USD 1.45 Billion by 20 …
The global molecular diagnostics in pharmacogenomics market is poised for substantial growth, with projections indicating an increase from USD 748.5 million in 2025 to USD 1,450.5 million by 2035. This represents a remarkable compound annual growth rate (CAGR) of 6.8%, resulting in nearly a 2X market expansion over the next decade. The rise of personalized medicine, increasing awareness of drug-gene interactions, and the expanded role of pharmacogenomics in clinical decision-making…
Pharmacogenomics Market to Grow at 9.3% CAGR Driven by Abbott, Affymetrix, Assur …
The pharmacogenomics (PGX) market is poised for significant growth in the coming years, driven by advancements in genetic testing and personalized medicine. As healthcare continues to shift towards more tailored approaches, the importance of understanding how an individual's genetic makeup influences their response to medications has become increasingly evident. This burgeoning field enables healthcare providers to optimize drug therapy, improving efficacy and minimizing adverse effects. The market is projected to…
Empowering Growth: Pharmacogenomic Services Outsourcing Market 2024 and Industry …
Market Overview:
Pharmacogenomic services outsourcing helps pharmaceutical and biotech companies in understanding the impact of genetic variations on drug responses by analyzing genomic variations in patients. This helps companies develop effective precision medicines and companion diagnostics.
Market Dynamics:
Pharmacogenomic services outsourcing market is expected to witness significant growth over the forecast period, owing to increasing investments by pharmaceutical companies in drug development activities and growing demand for personalized medicines. Further, increasing genomic research…
Demand For Pharmacogenomic (Pgx) Testing Is Slated To Rise At An 8% CAGR Through …
This research report on the worldwide Pharmacogenomic (PGx) Testing market analyses the market conditions and attain prominent aspects such as industry dynamics, key players, product segments, and leading applications. Besides this report presents insights into the global trends in the Pharmacogenomic (PGx) Testing market and recent developments in the market globally. The research is done keeping eye on the revenue potential and Pharmacogenomic (PGx) Testing market share. Apart from the…
Pharmacogenomic (PGx) Testing Market to Record Ascending Growth during 2021-2031 …
Pharmacogenomic (PGx) testing is study of the effect of individual genetic make-up on the therapeutic effect of the medication. The individual response to the medication is determined by the various factor such as weight, age, diet, habits, and genetic factors, etc. The genetic make-up of the individual majorly decides the metabolism rate of the medication along with other factors. Depending on the variation in person to person gene make-up, metabolism…
Pharmacogenomic (PGx) Testing Market Globally Expected to Drive Growth through 2 …
Pharmacogenomic (PGx) testing is study of the effect of individual genetic make-up on the therapeutic effect of the medication. The individual response to the medication is determined by the various factor such as weight, age, diet, habits, and genetic factors, etc.
The genetic make-up of the individual majorly decides the metabolism rate of the medication along with other factors. Depending on the variation in person to person gene make-up, metabolism of…
